2008
DOI: 10.1021/pr800112g
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of the Vitreous Proteome in Diabetes without Diabetic Retinopathy and Diabetes with Proliferative Diabetic Retinopathy

Abstract: An understanding of the diabetes-induced alterations in vitreous protein composition in the absence and in the presence of proliferative diabetic retinopathy (PDR) may provide insights into factors and mechanisms responsible for this disease. We have performed a comprehensive proteomic analysis and comparison of vitreous samples from individuals with diabetes but without diabetic retinopathy (noDR) or with PDR and nondiabetic individuals (NDM). Using preparative one-dimensional SDS-PAGE and nano-LC/MS/MS of 17… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

15
234
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 215 publications
(251 citation statements)
references
References 34 publications
15
234
1
Order By: Relevance
“…The vitreous levels of RAS components, including prorenin, angiotensinogen and angiotensin II, have been reported to increase in PDR eyes [33,34,40,41]. We confirmed the increased levels of prorenin (Fig.…”
Section: Discussionsupporting
confidence: 82%
See 1 more Smart Citation
“…The vitreous levels of RAS components, including prorenin, angiotensinogen and angiotensin II, have been reported to increase in PDR eyes [33,34,40,41]. We confirmed the increased levels of prorenin (Fig.…”
Section: Discussionsupporting
confidence: 82%
“…Activated prorenin (Fig. 6c) together with angiotensinogen [34,41] is thought to trigger tissue RAS activation causing angiotensin II generation [34,41] in PDR. Therefore s(P)RR accumulation in vitreous fluids, in concert with fl(P)RR in fibrovascular tissues, is likely to enhance tissue RAS activation in PDR.…”
Section: Discussionmentioning
confidence: 99%
“…Some previous studies pointed to reductions in the levels of vitreous PEDF in patients suffering from PDR [6,18-20]. Conversely, elevated levels of PEDF were detected in some studies [13,21]. We have detected reduced levels of PEDF in the vitreous fluid of diabetic patients with PDR by both proteomic analysis and Western blotting.…”
Section: Discussionmentioning
confidence: 43%
“…Previous studies have identified some proteins that are differentially expressed in the vitreous of PDR patients. Many of the proteins are involved in such processes as angiogenesis, cellular proliferation, acute phase response, vascular permeability changes, and oxygen-induced vessel loss [7,13]. These studies involved the use of vitreous from non-diabetic patients with macular hole (MH) or macular epiretinal membrane (MEM) as control groups.…”
Section: Introductionmentioning
confidence: 99%
“…1,2 Protein biomarkers in the vitreous core have been associated with diseases such as diabetic retinopathy. [3][4][5] How these proteins are differentially expressed in each of the substructures, and in many cases the specific protein identities, are not known. These details may give insight to the origin of proteins associated with specific vitreoretinal diseases and help target future therapies.…”
Section: Discussionmentioning
confidence: 99%